APA

Lam M. G. E. H., Dahmane A., Stevens W. H. M., van Rijk P. P., de Klerk J. M. H. & Zonnenberg B. A. (20080805). Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. : European journal of nuclear medicine and molecular imaging.

Chicago

Lam Marnix G E H, Dahmane Amel, Stevens Wil H M, van Rijk Peter P, de Klerk John M H and Zonnenberg Bernard A. 20080805. Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. : European journal of nuclear medicine and molecular imaging.

Harvard

Lam M. G. E. H., Dahmane A., Stevens W. H. M., van Rijk P. P., de Klerk J. M. H. and Zonnenberg B. A. (20080805). Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. : European journal of nuclear medicine and molecular imaging.

MLA

Lam Marnix G E H, Dahmane Amel, Stevens Wil H M, van Rijk Peter P, de Klerk John M H and Zonnenberg Bernard A. Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases. : European journal of nuclear medicine and molecular imaging. 20080805.